John Overdeck’s Axonics, Inc. Common Stock AXNX Stock Holding History

John Overdeck’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-81,605	Closed	-$4.45M	–	3344
2023 Q1	$4.45M	Buy	81,605 +8,395	+11%	+$490K	0.01%	967
2022 Q4	$4.58M	Sell	73,210 -65,985	-47%	-$4.38M	0.01%	897
2022 Q3	$9.8M	Buy	+139,195	New	+$9.6M	0.03%	493
2022 Q2	–	Sell	-5,899	Closed	-$369K	–	3037
2022 Q1	$369K	Sell	5,899 -40,495	-87%	-$2.18M	﹤0.01%	2145
2021 Q4	$2.6M	Buy	+46,394	New	+$2.84M	0.01%	1693
2021 Q3	–	Sell	-48,478	Closed	-$3.31M	–	4836
2021 Q2	$3.07M	Sell	48,478 -34,041	-41%	-$2.01M	0.01%	1537
2021 Q1	$4.94M	Buy	+82,519	New	+$4.49M	0.01%	1052
2019 Q4	–	Sell	-47,034	Closed	-$1.27M	–	4053
2019 Q3	$1.27M	Buy	+47,034	New	+$1.64M	﹤0.01%	1792

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

John Overdeck's AXNX Position: Q2 2023 in Review

John Overdeck sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 81,605 shares — an estimated $4.45M sold.

John Overdeck first reported a position in AXNX in Q3 2019 and held it in 8 quarters. The position peaked at $9.8M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

John Overdeck reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
John Overdeck sold 81,605 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $4.45M.
John Overdeck first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
John Overdeck's Axonics, Inc. Common Stock position peaked at $9.8M in Q3 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.